MTX-216 is an ATP-competitive inhibitor targeting both PI3K and EGFR. It simultaneously inhibits Ki-67 and ribosomal S6 phosphorylation, inducing apoptosis in NF1LOF cells. Additionally, MTX-216 suppresses SYK kinase activity with an IC50 of 281 nM. This compound is applicable for melanoma research.
Molekulargewicht:
502.348
CAS Nummer:
[1952236-19-9]
Formel:
C22H14Cl2FN5O2S
Target-Kategorie:
Syk|||Apoptosis|||EGFR|||PI3K
T206251
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
